Dr. Shuvo Roy is a distinguished professor of bioengineering and therapeutic sciences at the University of California, San Francisco, where he also holds a professorship in surgery. After earning his BS from Mount Union College in 1992, he completed both his MS in Electrical Engineering and Applied Physics and his PhD in Electrical Engineering and Computer Science at Case Western Reserve University in 1995 and 2001 respectively. His early career achievements included being named to MIT Technology Review's prestigious TR100 list of the world's top 100 young innovators in 2003, recognizing his groundbreaking work in biomedical microsystems. Prior to joining UCSF, Dr. Roy established himself as a leading innovator in medical device development during his tenure at the Cleveland Clinic, where his research focused on microelectromechanical systems for clinical applications.
Dr. Roy has pioneered the development of microelectromechanical systems (MEMS) technology for biomedical applications with particular emphasis on implantable devices, most notably as the technical director of The Kidney Project—an FDA Innovation Pathway 2.0 initiative to create an implantable bioartificial kidney for patients with end-stage renal disease. His laboratory has produced over 100 publications and secured 16 U.S. patents, with significant contributions to addressing the critical shortage of donor kidneys that affects approximately half a million Americans. Since co-founding the UCSF-Stanford Pediatric Device Consortium in 2009, he has overseen the advancement of 10 internally developed pediatric devices from concept to first-in-human trials and successfully guided three devices to market availability. His work has attracted more than $30 million in external funding, demonstrating the substantial clinical and commercial potential of his biomedical innovations.
As director of the Biodesign Laboratory at UCSF's Mission Bay campus, Dr. Roy leads a multidisciplinary research team that develops medical devices to address unmet clinical needs through strong collaboration across engineering and medical disciplines. He has cultivated an extensive network of scientific collaborators across Bay Area universities and the private sector, facilitating the translation of laboratory innovations into practical clinical solutions. His leadership extends to teaching medical device design courses at UCSF and lecturing internationally on the medical device development process. Currently, Dr. Roy continues to drive forward the development of the implantable artificial kidney, which promises to revolutionize treatment for end-stage renal disease by providing a viable alternative to both dialysis and transplantation, potentially transforming the lives of hundreds of thousands of patients worldwide.
